ArticleAmerican journal of preventive medicine2026
Trends in Mortality Rates for Cardiovascular Disease Subtypes Among Adults, 2010-2023.
Article in American journal of preventive medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Temporal and Regional Trends in Cardiovascular Mortality Associated With Diabetes Mellitus: A Nationwide Analysis From 1999 to 2020 in the United States.Health science reports · 2026Article
- Cardiomyopathy-related mortality in the United States, 1999 to 2023: A national population-based observational study.Medicine · 2026Observational
- Mortality Related to Different Circulatory Diseases Before, During and After the COVID-19 Pandemic.Clinical cardiology · 2026Article
- Thrombophilia and Folate Cycle Gene Polymorphisms in the Development of Ischemic Stroke After COVID-19.International journal of molecular sciences · 2026Article
- National trends and county-level geographic disparities in mortality from operationally defined cardiovascular-kidney-metabolic stages 4 and 4b in the United States.Frontiers in cardiovascular medicine · 2026Article
- Myocardial Scar and Cardiac Biomarker Levels as Predictors of Mortality After Acute Myocardial Infarction: A CMR-Based Long-Term Study.Diagnostics (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
introductionCardiovascular disease mortality rates, which had been declining in the decade before the COVID-19 pandemic, increased in 2020 and remained elevated through 2022. Understanding whether trends in mortality rates from 2010 to 2023 varied by cardiovascular disease subtypes could help focus prevention and clinical management.
methodsAnnual age-standardized mortality rates per 100,000 for U.S. adults were calculated in 2025 using National Vital Statistics System death counts from 2010 to 2023. Deaths with cardiovascular disease listed as the underlying cause of death were classified into 8 major cardiovascular disease subtypes. Temporal trends from 2010 to 2023 were evaluated using average annual percentage change.
resultsIn 2023, age-standardized mortality rates for cardiovascular disease subtypes were highest for ischemic heart disease (117.9 deaths per 100,000), followed by hypertensive disease (111.2), heart failure (82.1), cerebrovascular disease (65.7), arrhythmia (48.4), valvular heart disease (13.0), pulmonary heart disease (11.9), and cardiomyopathy (9.4). From 2010 to 2023, age-standardized mortality rates significantly declined for ischemic heart disease (average annual percentage change= -2.21) and cardiomyopathy (average annual percentage change= -3.00) and increased for hypertensive disease (average annual percentage change=2.52), arrhythmia (average annual percentage change=1.14), and pulmonary heart disease (average annual percentage change=1.38). Although the overall trend was not significant, age-standardized mortality rates were higher in 2023 than in 2010 for heart failure and lower for cerebrovascular disease and valvular heart disease.
conclusionsFrom 2010 to 2023, mortality rates improved for ischemic heart disease and cardiomyopathy but worsened for hypertensive disease, arrhythmia, and pulmonary heart disease. These results signal a need to focus prevention and clinical management efforts to target the growing burden of cardiovascular disease subtypes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.